Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL

Clinical trial NCT04638270 · UNKNOWN

Trial details

NCT number: NCT04638270
Sponsor: Xinqiao Hospital of Chongqing
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2020-11-21
Primary completion: 2021-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.